Latest Breaking News On - Cas ip services - Page 1 : comparemela.com

Reaching the triple point : practices of a successful scientific IP professional

Reaching the triple point : practices of a successful scientific IP professional
managingip.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from managingip.com Daily Mail and Mail on Sunday newspapers.

David saariPatent information users groupCas ip services

Webinar: Aligning Research & IP - Ensure Quality Results Through Collaboration - IPWatchdog com

With today’s accelerated pace of innovation, it is essential for organizations to leverage comprehensive IP insights to inform R&D, fuel strategic decisions, and protect their investments. At the same time, executing IP search projects in rapidly evolving domains is incredibly complex, requiring ongoing collaboration and alignment between R&D teams, attorneys, IP managers, and search professionals. Poor communication, incomplete or inaccurate…

Anne marie clarkChristine goddardSusanne goodsonPatent counsel at incyte corporationCas ip servicesIpwatchdog incGene quinnExecutive directorPatent counselIncyte corporationSenior scientist

This Week in Washington IP: Improving Invention Education, Intellectual Property Rights During Public Health Emergencies, and the State of the Chinese Economy

This week in Washington IP news, as a new school year begins, the United States Patent and Trademark Office (USPTO) looks at the latest research on invention education.

United statesCasimir jonesAndreas michaelisAnne marie clarkErin tochenLisal muellerRaymondn russellTrademark officeCovell tumminoIpwatchdog incInternational studiesAmerican enterprise instituteOffice of educationCas ip servicesOld dominion universityIndiana university

Webinar: Use Sequence Data to Strengthen Biologics Patent Claims and Applications - IPWatchdog com

Nearly 30% of biologics patent rejections result from a lack of adequate description. Rejections of this sort may rise in light of the Supreme Court’s decision in Amgen v. Sanofi. Increasingly, building strong patent applications in this complex and litigious biologics space will require more robust specifications, with solid and well-supported claims, which means applications backed by strong IP searches…

Anne marie clarkLisal muellerCasimir jonesRaymondn russellCovell tumminoIpwatchdog incCas ip servicesSupreme courtGene quinnSenior scientist

Webinar: Use Sequence Data to Strengthen Biologics Patent Claims and Applications - Sponsored by CAS - IPWatchdog com

Nearly 30% of biologics patent rejections result from a lack of adequate description. Rejections of this sort may rise in light of the Supreme Court’s decision in Amgen v. Sanofi. Increasingly, building strong patent applications in this complex and litigious biologics space will require more robust specifications, with solid and well-supported claims, which means applications backed by strong IP searches…

United statesRaymondn russellAnne marie clarkCasimir jonesLisal muellerAmerican chemical societyCas ip servicesSupreme courtIpwatchdog incCovell tumminoGene quinnSenior scientistAmerican chemical